MedTrace Logo

A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX

NCT02383901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 116

Last updated 2016-09-05

No results posted yet for this study

Summary

The purpose of this study is to investigate to which extend osteosarcoma patients do NOT meet the criteria for successfully advancement to next planned chemotherapy course.

Conditions

Interventions

DRUG

Methotrexate

The study includes osteosarcoma patients who have received MAP treatment, MAP treatment contains 12 courses of Methotrexate

Sponsors & Collaborators

  • Isofol Medical AB

    lead INDUSTRY

Principal Investigators

  • Mikael Eriksson, MD PhD. · Skåne Universitiy Hospital

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-09-30
Completion
2016-05-31

Countries

  • Hungary
  • Norway
  • Poland
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02383901 on ClinicalTrials.gov